Home/Filings/4/0000899243-22-004605
4//SEC Filing

Barry Douglas 4

Accession 0000899243-22-004605

CIK 0001819133other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:30 PM ET

Size

5.5 KB

Accession

0000899243-22-004605

Insider Transaction Report

Form 4
Period: 2022-02-01
Barry Douglas
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-01+69,50069,500 total
    Exercise: $9.22Exp: 2032-02-01Common Stock (69,500 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2023, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Issuer

Tango Therapeutics, Inc.

CIK 0001819133

Entity typeother

Related Parties

1
  • filerCIK 0001890662

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:30 PM ET
Size
5.5 KB